Holen Sie sich die Stockscreener-App
1.245
2.89%
0.035
Schlusskurs vom Vortag:
$1.21
Offen:
$1.225
24-Stunden-Volumen:
34,139
Relative Volume:
0.17
Marktkapitalisierung:
$8.55M
Einnahmen:
$3.19M
Nettoeinkommen (Verlust:
$-10.42M
KGV:
-0.0351
EPS:
-35.4757
Netto-Cashflow:
$-10.65M
1W Leistung:
-1.19%
1M Leistung:
-42.36%
6M Leistung:
-18.63%
1J Leistung:
-53.20%
1-Tages-Spanne:
$1.19
$1.26
1-Wochen-Bereich:
$1.18
$1.26
52-Wochen-Spanne:
$1.00
$3.04
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Firmenname
Intelligent Bio Solutions Inc
Sektor
Branche
Telefon
646-233-6971
Adresse
135 W 41ST ST,, NEW YORK
Vergleichen Sie INBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.245 | 8.55M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
131.59 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
94.80 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
347.64 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.51B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.48 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
Intelligent Bio Solutions Adds Latin American Spanish To Drug Screening System To Expand Reach - Nasdaq
Intelligent Bio Solutions (INBS) Expands Language Options in Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System | INBS Stock News - GuruFocus
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System - The Manila Times
Intelligent Bio Solutions Expands Drug Screening Reach: Eyes Massive $1.1B Latin American Market Opportunity - Stock Titan
Intelligent Bio Solutions Files For Mixed Shelf Of Up To $100 MillionSEC Filing - MarketScreener
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - The Globe and Mail
Intelligent Bio Solutions (NASDAQ:INBS) Trading Up 7% – Time to Buy? - Defense World
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win - MSN
U.S. Patent Granted to Intelligent Bio Solutions for Drug Screening Tech - Medical Product Outsourcing
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System - The Manila Times
Major Market Expansion: Drug Screening Tech Now Reaches 450 Million Arabic Speakers - Stock Titan
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show - The Manila Times
Game-Changing Drug Testing Technology: Non-Invasive Solution Poised for Major US Launch - Stock Titan
MasterCard : Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry - MarketScreener
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra - The Manila Times
Intelligent Bio Solutions Highlights Continued Expansion With Strategic Partnership In Spain And Andorra - MarketScreener
Major Expansion: Intelligent Bio Solutions Captures $448M Spanish Drug Testing Market with 1,000 Monthly Orders - Stock Titan
US patent granted for INBS’ fingerprint drug screening technology - Yahoo
Intelligent Bio Solutions secures new U.S. patent By Investing.com - Investing.com South Africa
Intelligent Bio Solutions Secures U.S. Patent for Drug Screening - TipRanks
Intelligent Bio Solutions secures new U.S. patent - Investing.com
Intelligent Bio Solutions Granted U.S. Patent For Fingerprinting Drug Screening Cartridge - Marketscreener.com
Revolutionary Fingerprint Drug Test Secures Game-Changing Patent for 2025 US Launch - Stock Titan
EXCLUSIVE: Intelligent Bio Solutions Adds Sixth US Patent For Its Drug Screening Technology - Benzinga
Intelligent Bio Solutions On Track For 2025 U.S. Launch Of FDA-Cleared Fingerprint Drug Test - Nasdaq
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch - The Manila Times
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch - TradingView
Revolutionary Drug Screening System Achieves 94% Accuracy in FDA Submission Data - Stock Titan
EXCLUSIVE: FDA Seeks Additional Information For Intelligent Bio Solutions' Drug Screening System, Clearance Process Remains on Track For 2025 US Launch - Yahoo
Intelligent Bio Solutions Anticipates Sixth U.S. Patent Approval - TipRanks
Intelligent Bio Solutions Expecting to Get US Patent to Enhance Protection of Lateral Flow Technology - Marketscreener.com
Intelligent Bio Solutions Inc. Announces Anticipated Sixth Patent for Lateral Flow Technology in Drug Testing Solution - Nasdaq
Intelligent Bio Solutions set to secure new US patent - Investing.com
Intelligent Bio Solutions to Expand U.S. IP Portfolio with Expected Patent Grant - The Manila Times
Revolutionary Fingerprint Drug Test Patent Strengthens Intelligent Bio Solutions Market Position - Stock Titan
Intelligent Bio Solutions to Offer Additional Common Stock By Investing.com - Investing.com Australia
Intelligent Bio Solutions to Offer Additional Common Stock - Investing.com
Intelligent Bio Solutions to Participate in the iAccess Virtual Best Ideas Spring Conference on March 25th and 26th - The Manila Times
Intelligent Bio Solutions Reveals Growth Strategy at Elite Investor Conference March 25 - StockTitan
Intelligent Bio Solutions closes public offering of common stock - Medical Buyer
Intelligent Bio Solutions Inc (INBS) Should Be Considered For The Next Few Weeks - Stocks Register
Navient finalizes sale of Government Services business - The Manila Times
Intelligent Bio Solutions shares fall on proposed offering of common stock - MSN
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock - The Manila Times
Intelligent Bio Solutions Inc. Closes $3 Million Public Offering of Common Stock - Nasdaq
Can This $3M Capital Raise Transform Intelligent Bio Solutions' Future? - StockTitan
Intelligent Bio Solutions announces pricing of $2.6 million public offering; shares fall - MSN
Intelligent Bio Solutions sets $2 public stock offering By Investing.com - Investing.com Nigeria
Intelligent Bio Solutions Inc. Announces $2.6 Mln Common Stock Offering Pricing - Nasdaq
Intelligent Bio Solutions sets $2 public stock offering - Investing.com
Finanzdaten der Intelligent Bio Solutions Inc-Aktie (INBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):